Business Description
Addex Therapeutics Ltd
ISIN : CH0029850754
Description
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 46.57 | |||||
Equity-to-Asset | -0.41 | |||||
Debt-to-Equity | -0.03 | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | -160.46 | |||||
Beneish M-Score | -8.47 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -45.4 | |||||
3-Year EBITDA Growth Rate | 33.3 | |||||
3-Year EPS without NRI Growth Rate | 33.3 | |||||
3-Year FCF Growth Rate | 38.3 | |||||
3-Year Book Growth Rate | -74.4 | |||||
Future 3-5Y Total Revenue Growth Rate | 140.1 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 14.66 | |||||
9-Day RSI | 27.03 | |||||
14-Day RSI | 33.6 | |||||
6-1 Month Momentum % | -72.82 | |||||
12-1 Month Momentum % | -72.82 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.71 | |||||
Quick Ratio | 0.71 | |||||
Cash Ratio | 0.35 | |||||
Days Sales Outstanding | 48.63 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -66.5 | |||||
Shareholder Yield % | -1.32 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | -644.68 | |||||
Net Margin % | -835.39 | |||||
FCF Margin % | -582.23 | |||||
ROE % | -403.8 | |||||
ROA % | -184.75 | |||||
ROIC % | -1082.25 | |||||
ROC (Joel Greenblatt) % | -3400.31 | |||||
ROCE % | -295.03 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 3.41 | |||||
EV-to-EBIT | -0.66 | |||||
EV-to-EBITDA | -0.68 | |||||
EV-to-Revenue | 4.34 | |||||
EV-to-FCF | -0.75 | |||||
Earnings Yield (Greenblatt) % | -151.52 | |||||
FCF Yield % | -105.27 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Addex Therapeutics Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil CHF) | 1.345 | ||
EPS (TTM) (CHF) | -0.13 | ||
Beta | 2.46 | ||
Volatility % | 72.45 | ||
14-Day RSI | 33.6 | ||
14-Day ATR (CHF) | 0.000431 | ||
20-Day SMA (CHF) | 0.064 | ||
12-1 Month Momentum % | -72.82 | ||
52-Week Range (CHF) | 0.0554 - 0.2355 | ||
Shares Outstanding (Mil) | 128.27 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Addex Therapeutics Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Addex Therapeutics Ltd Stock Events
Event | Date | Price(CHF) | ||
---|---|---|---|---|
No Event Data |
Addex Therapeutics Ltd Frequently Asked Questions
What is Addex Therapeutics Ltd(LTS:0QNV)'s stock price today?
When is next earnings date of Addex Therapeutics Ltd(LTS:0QNV)?
Does Addex Therapeutics Ltd(LTS:0QNV) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |